Provide feedbackProvide feedback

Home :: Rheumatology

Lyon Schuss, fixed flexion radiographs provide similar reproducibility for joint space width but differences in joint space narrowing

Thursday, November 13 2008 | Comments
Evidence Grade 3 What's This?

Lyon Schuss (LS) and fixed flexion (FF) radiographs provide similar reproducibility in the measurement of joint space width, but the LS view is much more sensitive in evaluating joint space narrowing in osteoarthritis (OA) knees, according to a recent head-to-head trial. The analysis included 161 women aged >=40 years and in good general health. Sixty-two patients had radiographic OA at baseline and 99 were age- and sex-matched controls without OA. Patients and controls were similar in age...

Lyon Schuss (LS) and fixed flexion (FF) radiographs provide similar reproducibility in the measurement of joint space width, but the LS view is much more sensitive in evaluating joint space narrowing in osteoarthritis (OA) knees, according to a recent head-to-head trial.

The analysis included 161 women aged >=40 years and in good general health. Sixty-two patients had radiographic OA at baseline and 99 were age- and sex-matched controls without OA. Patients and controls were similar in age (57.2 years vs 56.0 years, respectively), but had substantial differences in body mass index (36.9 vs 25.1, respectively) and in Western Ontario and McMaster Universities OA Index pain scores (6.3 vs 1.0, respectively).

The OA and control knees were imaged twice on the same day with LS and FF views at baseline and at 12 months. The investigators measured minimum joint space width using a computer, and assessed medial tibial plateau alignment from the distance between anterior and posterior margins of the medial tibial plateau (intermargin distance). Reproducibility of measurements of minimum joint space width and sensitivity to change were evaluated.

Joint space width in healthy knees did not vary with either view over 12 months. However, in OA knees, the 2 views differed significantly in detecting mean 12-month joint space narrowing (0.22 mm with the LS view, P=.0002; -0.01 mm with the FF view, P=.92). At both baseline and 12-month examinations, mean intermargin distance was approximately twice as large in the FF view as in the LS view (1.9 mm vs 0.9 mm; P<.0001).

"These findings have practical implications: an interval of only 12 months was sufficient to detect joint space narrowing with the LS, but not FF, view of OA knees," the authors wrote. "In an observational study, increasing the duration of follow-up or the sample size may overcome the limitations of the FF technique. However, in a clinical trial attempting to demonstrate slowing of joint space narrowing by a structure modifying drug for OA, those limitations would require exposure of a larger number of subjects to possible adverse effects of the test drug than use of the LS protocol." (Graverand M-P, et al. Ann Rheum Dis 2008;67:1562-1566.)

Latest News

Oral JAK-3 inhibitor plus methotrexate efficacious, safe in RA Verusmed

Thursday, October 30 2008 | Comments
Evidence Grade 7 What's This?
By David MacDougall

CP-690,550, an oral inhibitor of Janus kinase 3 (JAK-3), is safe and efficacious when used in combination with methotrexate in patients with rheumatoid arthritis (RA) who have had an inadequate response to methotrexate alone, according to findings from a double-blind, Phase IIb, dose-finding study.

JAK-3 is a tyrosine kinase essential for proper signal transduction downstream of selected cytokine...
Tags: Arthritis


Long-term treatment with adalimumab benefits patients with AS Verusmed

Thursday, October 30 2008 | Comments
Evidence Grade 7 What's This?
By David MacDougall

Adalimumab treatment is associated with significant improvements in the signs and symptoms of ankylosing spondylitis (AS), with effectiveness sustained after 3 years of treatment, according to new data.

In the ATLAS trial, 315 patients with AS were randomized to receive 40 mg of adalimumab or placebo every other week for 24 weeks. The primary study endpoint was the proportion of patients at week 12...
Tags: Arthritis


Vitamin D deficiency commonly underlies initiation, progression of rheumatologic disorders Verusmed

Thursday, October 30 2008 | Comments
Evidence Grade 3 What's This?
By David MacDougall

Vitamin D deficiency may be a common underlying factor in the initiation and progression of rheumatoid arthritis (RA) and other rheumatologic disorders, according to Dr. Ann Cranney with the division of rheumatology at The Ottawa Hospital.

Studies of vitamin D deficiency have yielded variable estimates of the prevalence of this condition and...

Targeted therapies for RA may represent dawn of era of personalized medicine, expert panel reports Verusmed

Wednesday, October 29 2008 | Comments
Evidence Grade 3 What's This?
By Hunter Kaller

Modern targeted therapies for rheumatoid arthritis (RA) provide rheumatologists with an opportunity to tailor treatment strategies to a patient's individual characteristics, and this opportunity for personalized medicine is likely to expand as new agents and diagnostic tests are developed, according to a panel of researchers.

In...
Tags: Arthritis






Rheumatology Conference Coverage